Cencora, Inc. (COR) Financial Statements
Industry: Drugs, Proprietaries & Druggists' Sundries (Wholesale)
In fiscal 2025, Cencora reported revenue of $321.33B, up 9.3% from $293.96B the year before. Net income was $1.55B (a 0.5% net margin), or $7.96 per diluted share. Gross margin was 3.6% and operating margin was 0.8%. Operating activities generated $3.88B of cash, leaving $3.21B of free cash flow. At fiscal year end, Cencora held $76.59B in total assets against $75.08B in total liabilities, including $4.36B of cash and equivalents.
Open the full interactive Cencora financials → Quarterly statements, key ratios, valuation history and price charts.
Cencora Key Stats
| Share Price | $330.11 |
|---|---|
| Market Cap | $64.02B |
| P/E Ratio | 41.5 |
| Revenue YoY Growth | +9.3% |
| 52-Week Range | $251.67 – $372.53 |
| Shares Outstanding | 193.1 million (basic, 2026 Q3) |
Cencora Income Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $189.89B | $213.99B | $238.59B | $262.17B | $293.96B | $321.33B |
| Cost of Goods Sold | $184.70B | $207.05B | $230.29B | $253.21B | $284.05B | $309.85B |
| Gross Profit | $5.19B | $6.94B | $8.30B | $8.96B | $9.91B | $11.48B |
| Operating Income | -$5.14B | $2.35B | $2.37B | $2.34B | $2.18B | $2.63B |
| Pre-Tax Income | -$5.29B | $2.22B | $2.18B | $2.16B | $2.00B | $2.26B |
| Income Tax | -$1.89B | $677.3M | $516.5M | $428.3M | $484.7M | $690.5M |
| Net Income | -$3.41B | $1.54B | $1.70B | $1.75B | $1.51B | $1.55B |
| Diluted EPS | -$16.65 | $7.39 | $8.04 | $8.53 | $7.53 | $7.96 |
Cencora Quarterly Results
| 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | |
|---|---|---|---|---|
| Revenue | $83.73B | $85.93B | $78.36B | $84.75B |
| Net Income | -$339.7M | $559.6M | $1.64B | $763.5M |
| Diluted EPS | -$1.74 | $2.87 | $8.40 | $3.94 |
Cencora Balance Sheet
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $4.60B | $2.55B | $3.39B | $2.59B | $3.13B | $4.36B |
| Current Assets | $33.06B | $38.80B | $39.59B | $42.80B | $47.72B | $52.24B |
| Total Assets | $44.27B | $57.34B | $56.56B | $62.56B | $67.10B | $76.59B |
| Current Liabilities | $33.85B | $41.36B | $43.48B | $48.83B | $54.28B | $57.82B |
| Total Long-Term Debt | $3.62B | $6.68B | $5.70B | $4.79B | $4.39B | $7.66B |
| Total Liabilities | $45.29B | $57.11B | $56.77B | $62.04B | $66.46B | $75.08B |
| Shareholders' Equity | -$1.02B | $223.4M | -$211.6M | $522.0M | $645.9M | $1.51B |
Cencora Cash Flow Statement
| FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|---|
| Cash From Operations | $2.21B | $2.67B | $2.70B | $3.91B | $3.48B | $3.88B |
| Cash From Investing | -$379.9M | -$6.14B | -$368.4M | -$2.60B | -$618.1M | -$4.98B |
| Cash From Financing | -$603.6M | $1.95B | -$1.75B | -$2.22B | -$2.33B | $2.25B |
| Free Cash Flow | $1.84B | $2.23B | $2.21B | $3.45B | $3.00B | $3.21B |
Figures from Cencora's 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Cencora financials page for every line item.
Cencora Company Profile
| Ticker | COR |
|---|---|
| Exchange | NYSE |
| Industry | Drugs, Proprietaries & Druggists' Sundries (Wholesale) |
| Headquarters | Conshohocken, Pennsylvania |
| Incorporated in | Delaware |
| Fiscal Year End | September 30 |
| SEC Filer Category | Large accelerated filer |
| SEC CIK | 0001140859 |
Frequently Asked Questions
What was Cencora's revenue in fiscal 2025?
Cencora (COR) reported revenue of $321.33B for fiscal 2025.
What is Cencora's annual revenue history?
Cencora's annual revenue by fiscal year: 2020: $189.89B; 2021: $213.99B; 2022: $238.59B; 2023: $262.17B; 2024: $293.96B; 2025: $321.33B.
What was Cencora's net income in fiscal 2025?
Cencora reported net income of $1.55B for fiscal 2025.
What was Cencora's earnings per share (EPS) in fiscal 2025?
Cencora's diluted EPS was $7.96 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Cencora generate in fiscal 2025?
Cencora generated $3.21B of free cash flow in fiscal 2025.
What was Cencora's revenue last quarter?
In its most recent reported quarter (2026 Q3), Cencora reported revenue of $84.75B.
How much debt does Cencora have?
Cencora reported $7.66B of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Cencora are outstanding?
Cencora reported a weighted average of 193.1 million basic shares outstanding in 2026 Q3.
What is Cencora's market cap?
Based on its latest closing price, Cencora (COR) has a market capitalization of about $64.02B.
When does Cencora's fiscal year end?
Cencora's fiscal year end, as registered with the SEC, is September 30.
Where is Cencora headquartered?
Cencora lists its business address in Conshohocken, Pennsylvania in its SEC filings.